Standard Biotools Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Standard Biotools Stock Summary

Standard Biotools competes with Varex Imaging, CeriBell, Cullinan Oncology, Avanos Medical, and So Young. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California. Standard Biotools operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 615 people.

Standard Biotools Key Financial Ratios

Standard Biotools Key Balance Sheet Accounts

Standard Biotools Key Income Statement Accounts

Standard Biotools Key Cash Accounts

Standard Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Standard Biotools's current stock value. Our valuation model uses many indicators to compare Standard Biotools value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Standard Biotools competition to find correlations between indicators driving Standard Biotools's intrinsic value. More Info.Standard Biotools is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Standard Biotools' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Standard Biotools' earnings, one of the primary drivers of an investment's value.

Standard Biotools Systematic Risk

Today, most investors in Standard Biotools Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Standard Biotools' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Standard Biotools growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Standard Biotools help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Standard Biotools. We use our internally-developed statistical techniques to arrive at the intrinsic value of Standard Biotools based on widely used predictive technical indicators. In general, we focus on analyzing Standard Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Standard Biotools's daily price indicators and compare them against related drivers.

When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.